Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 4/2013

01.11.2013

Comparison of three medication adherence measures in patients taking warfarin

verfasst von: Ye Wang, Ming Chai Kong, Yu Ko

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

In order to improve warfarin adherence, we must first know the rate of non-adherence and the reasons for it. Assessment of warfarin adherence is important in improving patients’ warfarin-taking behavior and International Normalized Ratio (INR) control. This study aimed to compare three medication adherence measures in patients taking warfarin: the 8-item Morisky Medication Adherence Scale (MMAS), the 100-point Visual Analogue Scale (VAS) and medication refill adherence (MRA). A cross-sectional observational study was conducted in a convenience sample of 174 patients taking warfarin at an anticoagulation clinic. A survey questionnaire that included the MMAS, VAS, and demographic and warfarin-related clinical questions was administered to patients in English or Chinese depending on their preferences. The MRA and INR values were retrieved from hospital electronic databases. Most participants were adherent to warfarin as indicated by the three measures. A weak association was found between the MMAS and the other two adherence measures. The MMAS and MRA were associated with the percentage of INRs within range in the past 2 weeks. Moreover, the MRA was weakly associated with time within the therapeutic INR range in the past 3 months and 2 weeks. The findings provide insights into the differences among three medication adherence measures and may assist healthcare providers to select the most suitable measure for the assessment of warfarin adherence.
Literatur
1.
Zurück zum Zitat Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:204S–233SPubMedCrossRef Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E (2004) The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:204S–233SPubMedCrossRef
2.
Zurück zum Zitat Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S (2004) Hemorrhagic complications of anticoagulant treatment: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:287S–310SPubMedCrossRef Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S (2004) Hemorrhagic complications of anticoagulant treatment: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:287S–310SPubMedCrossRef
3.
Zurück zum Zitat Merli GJ, Tzanis G (2009) Warfarin: what are the clinical implications of an out-of-range-therapeutic International Normalized Ratio? J Thromb Thrombolysis 27:293–299PubMedCrossRef Merli GJ, Tzanis G (2009) Warfarin: what are the clinical implications of an out-of-range-therapeutic International Normalized Ratio? J Thromb Thrombolysis 27:293–299PubMedCrossRef
4.
Zurück zum Zitat Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026PubMedCrossRef Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026PubMedCrossRef
5.
Zurück zum Zitat Wittkowsky AK, Devine EB (2004) Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy 24:1311–1316PubMedCrossRef Wittkowsky AK, Devine EB (2004) Frequency and causes of overanticoagulation and underanticoagulation in patients treated with warfarin. Pharmacotherapy 24:1311–1316PubMedCrossRef
6.
Zurück zum Zitat Waterman AD, Milligan PE, Bayer L, Banet GA, Gatchel SK, Gage BF (2004) Effect of warfarin nonadherence on control of the International Normalized Ratio. Am J Health Syst Pharm 61:1258–1264PubMed Waterman AD, Milligan PE, Bayer L, Banet GA, Gatchel SK, Gage BF (2004) Effect of warfarin nonadherence on control of the International Normalized Ratio. Am J Health Syst Pharm 61:1258–1264PubMed
7.
Zurück zum Zitat Hixson-Wallace JA, Dotson JB, Blakey SA (2001) Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost 7:33–37PubMedCrossRef Hixson-Wallace JA, Dotson JB, Blakey SA (2001) Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin Appl Thromb Hemost 7:33–37PubMedCrossRef
9.
Zurück zum Zitat Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. a comprehensive review. J Clin Pharm Ther 26:331–342PubMedCrossRef Vermeire E, Hearnshaw H, Van Royen P, Denekens J (2001) Patient adherence to treatment: three decades of research. a comprehensive review. J Clin Pharm Ther 26:331–342PubMedCrossRef
10.
Zurück zum Zitat Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:348–354CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:348–354CrossRef
11.
Zurück zum Zitat Hess LM, Raebel MA, Conner DA, Malone DC (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 40:1280–1288PubMedCrossRef Hess LM, Raebel MA, Conner DA, Malone DC (2006) Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother 40:1280–1288PubMedCrossRef
12.
Zurück zum Zitat Orensky IA, Holdford DA (2005) Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic. Pharmacotherapy 25:1801–1808PubMedCrossRef Orensky IA, Holdford DA (2005) Predictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinic. Pharmacotherapy 25:1801–1808PubMedCrossRef
13.
Zurück zum Zitat Platt AB, Localio AR, Brensinger CM et al (2010) Can we predict daily adherence to warfarin?: results from the International Normalized Ratio adherence and genetics (IN-RANGE) study. Chest 137:883–889PubMedCrossRef Platt AB, Localio AR, Brensinger CM et al (2010) Can we predict daily adherence to warfarin?: results from the International Normalized Ratio adherence and genetics (IN-RANGE) study. Chest 137:883–889PubMedCrossRef
14.
Zurück zum Zitat Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15:59–66PubMed Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15:59–66PubMed
15.
Zurück zum Zitat Sakthong P, Chabunthom R, Charoenvisuthiwongs R (2009) Psychometric properties of the thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother 43:950–957PubMedCrossRef Sakthong P, Chabunthom R, Charoenvisuthiwongs R (2009) Psychometric properties of the thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother 43:950–957PubMedCrossRef
16.
Zurück zum Zitat Palareti G, Legnani C, Guazzaloca G et al (2005) Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol 129:72–78PubMedCrossRef Palareti G, Legnani C, Guazzaloca G et al (2005) Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol 129:72–78PubMedCrossRef
17.
Zurück zum Zitat Al-Qazaz H, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE (2010) The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract 90:216–221PubMedCrossRef Al-Qazaz H, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE (2010) The eight-item Morisky medication adherence scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract 90:216–221PubMedCrossRef
18.
Zurück zum Zitat Sweileh WM, Ihbesheh MS, Jarar IS et al (2011) Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 21:301–305PubMedCrossRef Sweileh WM, Ihbesheh MS, Jarar IS et al (2011) Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 21:301–305PubMedCrossRef
19.
Zurück zum Zitat Nau DP, Steinke DT, Williams LK, Austin R, Lafata JE, Divine G, Pladevall M (2007) Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother 41:1792–1797PubMedCrossRef Nau DP, Steinke DT, Williams LK, Austin R, Lafata JE, Divine G, Pladevall M (2007) Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother 41:1792–1797PubMedCrossRef
20.
Zurück zum Zitat Bozek A, Jarzab J (2010) Adherence to asthma therapy in elderly patients. J Asthma 47:162–165PubMedCrossRef Bozek A, Jarzab J (2010) Adherence to asthma therapy in elderly patients. J Asthma 47:162–165PubMedCrossRef
21.
Zurück zum Zitat Berg KM, Wilson IB, Li X, Arnsten JH (2012) Comparison of antiretroviral adherence questions. AIDS Behav 16:461–468PubMedCrossRef Berg KM, Wilson IB, Li X, Arnsten JH (2012) Comparison of antiretroviral adherence questions. AIDS Behav 16:461–468PubMedCrossRef
22.
Zurück zum Zitat Choo PW, Rańd CS, Inui TS et al (1999) Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37:846–857PubMedCrossRef Choo PW, Rańd CS, Inui TS et al (1999) Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37:846–857PubMedCrossRef
23.
Zurück zum Zitat Zeller A, Ramseier E, Teagtmeyer A, Battegay E (2008) Patients’ self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 31:2037–2043PubMedCrossRef Zeller A, Ramseier E, Teagtmeyer A, Battegay E (2008) Patients’ self-reported adherence to cardiovascular medication using electronic monitors as comparators. Hypertens Res 31:2037–2043PubMedCrossRef
Metadaten
Titel
Comparison of three medication adherence measures in patients taking warfarin
verfasst von
Ye Wang
Ming Chai Kong
Yu Ko
Publikationsdatum
01.11.2013
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 4/2013
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-0872-5

Weitere Artikel der Ausgabe 4/2013

Journal of Thrombosis and Thrombolysis 4/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.